Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Coursey

Vascular & Interventional Radiology Greeley, CO Medical Doctor

NPI 1821294695 CMS profile 264857

1801 16Th St, Ste 300, Greeley, CO 80631

Open in the dashboard

General payments

$31,097

206 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Coursey of Greeley, CO is reported in the CMS Open Payments database as having received $31,097 across 206 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,362 44
2024 General $11,931 47
2023 General $853 43
2022 General $1,465 31
2021 General $279 7
2020 General $2,361 16
2019 General $1,846 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Coursey
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Richard Coursey were reported at $12,362. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Richard Coursey Vascular & Interventional Radiology median Middle half National median
2019 $1,846 $422 $125–$1,555 $163
2020 $2,361 $200 $68–$652 $114
2021 $279 $280 $99–$866 $132
2022 $1,465 $433 $137–$1,497 $149
2023 $853 $506 $152–$2,019 $160
2024 $11,931 $556 $175–$1,930 $164
2025 $12,362 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $25,410 127 payments
  2. Bard Peripheral Vascular, Inc. $2,337 13 payments
  3. Medtronic USA, Inc. $1,813 19 payments
  4. Argon Medical Devices, Inc. $278 4 payments
  5. SPR Therapeutics, Inc $261 8 payments
  6. Boston Scientific Corporation $220 8 payments
  7. AngioDynamics, Inc. $207 12 payments
  8. Inari Medical, Inc. $205 2 payments
  9. Penumbra, Inc. $107 1 payment
  10. Siemens Medical Solutions USA, Inc. $84 4 payments
  11. Other $175 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,000 6 payments
  2. Travel and Lodging $7,716 25 payments
  3. Consulting Fee $6,550 3 payments
  4. Food and Beverage $4,831 172 payments
Products named General payments · program years 2019–2025
  1. SYNCHROMEDII $9,799 20 payments
  2. INTELLIS ADAPTIVESTIM $9,020 74 payments
  3. KYPHON EXPRESS II KYPHOPAK TRAY $5,067 5 payments
  4. INTELLIS $1,259 7 payments
  5. LUTONIX $1,192 2 payments
  6. FLOWTRIEVER CATHETER, S $390 3 payments
  7. OSTEOCOOL RF ABLATION $372 4 payments
  8. SPRINT PNS System $261 8 payments
  9. OSTEOCOOL RF ABLATION SYSTEM $260 9 payments
  10. KYPHON Balloon Kyphoplasty $182 8 payments
  11. Other $1,221 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

159

Median for Interventional Radiology: 38

Drug cost

$1,726

Median for Interventional Radiology: $333

Branded share of claims

34%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Duloxetine Hcl Generic 21 $414
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 26 $335
Cilostazol Generic 13 $310
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 28 $224
Amlodipine Besylate Generic 13 $174
Gabapentin Generic 18 $149
Tramadol Hcl Generic 40 $123

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 131 billing codes

Paid by Medicare

$62,591

Medicare's payments for the services billed

Medicare patients

226

Average age 72

Services billed

680

123 women, 103 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 68%
Depression 35%
Chronic kidney disease 33%
Cancer 32%
Diabetes 31%
Ischemic heart disease 29%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

206 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record